Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature.
about
In Vivo Confocal Microscopy of the Human Cornea in the Assessment of Peripheral Neuropathy and Systemic DiseasesChemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspectiveTherapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral NeuropathyRepurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agentFufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathwaysPlatinum-induced neurotoxicity and preventive strategies: past, present, and futureMeasuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment ScaleBevacizumab Exacerbates Paclitaxel-Induced Neuropathy: A Retrospective Cohort Study.Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy.Chemotherapy-induced peripheral neuropathy: Current status and progress.Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer.An Application of the Multivariate Linear Mixed Model to the Analysis of Shoulder Complexity in Breast Cancer Patients.Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction deviceEffects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons.The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathyA prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice.Bortezomib-induced peripheral neurotoxicity: an update.Mechanisms of distal axonal degeneration in peripheral neuropathies.Re-purposing cryoablation: a combinatorial 'therapy' for the destruction of tissue.Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.Neuromuscular issues in systemic disease.Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics.The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice.Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy.The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanomaManagement of peripheral neuropathy induced by chemotherapy in adults with cancer: a review.Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis.Spinal astrocyte gap junction and glutamate transporter expression contributes to a rat model of bortezomib-induced peripheral neuropathy.Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity.A novel path to chronic proprioceptive disability with oxaliplatin: Distortion of sensory encoding.Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN).Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery.Microtubule-Targeting Agents Eribulin and Paclitaxel Differentially Affect Neuronal Cell Bodies in Chemotherapy-Induced Peripheral Neuropathy.The Content Validity of a Chemotherapy-Induced Peripheral Neuropathy Patient-Reported Outcome Measure.Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome.Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
P2860
Q26771756-F840297F-23C6-4423-8A84-E80720B910E9Q26777967-44A854BE-9F1D-4CFA-B69D-84035350F99DQ28075341-0E746D95-69A2-4C2F-8DDC-70ED96BF3B24Q33893928-623FA6C4-F2C4-424B-90DC-83A61A1E11D9Q34619815-34D2B476-D90B-4757-BD56-05EFE6341BF7Q35345734-5C28731D-CFAB-40A4-9739-FEE56F7642ADQ36117942-3669F622-1419-467D-A8D0-B5A58B864B20Q36228462-00C6072B-FB7B-4987-A12C-FD1BB2690EE2Q36261283-D83C8735-4F8A-4EF2-8BC8-FB9625A82587Q36421901-EFA9A2C7-A25B-4D2C-8393-68DFD3AC7785Q36693127-0A06B2A7-2761-4DFA-9BC7-B041DE2C4C0DQ36732329-753B9043-CEAA-4B05-9E9E-7607AE330446Q37375212-E5C5B081-6933-4BBA-BE19-8B6E275F2770Q37411688-634F3199-331A-4BCB-A7E6-EB4DB9BDA922Q37417070-4EE7B069-51BD-409E-9648-03EB4F17FA2FQ37582203-F30DD8AE-16DC-48A3-8C41-F2A0E248368FQ37734620-2200587C-5DAD-431C-AFC2-965D3BDBD55AQ38234733-780F17C3-BB14-4487-A447-A8C2BBFE8345Q38330759-7B279171-E98D-445E-A1FD-1C99FF43C43BQ38333001-C00F0D6A-E26D-4262-9DB2-4A139E99FCD2Q38370562-63DDEC3C-9F30-4B40-BAE4-3A261241D1FBQ38501865-25263E3D-D74D-4FBD-B4B2-EF51BA7A5F9CQ38664595-29751A08-7814-4642-9FA6-DEA20F77B695Q38700984-6B57D8D6-40E8-4256-8AF1-D7738EC9A172Q38722948-3A5871F9-8AF0-4A9F-B547-B34902A9DD3EQ38740918-B10F7F38-F9EE-4A75-AEDB-F556EDEF9C68Q38981033-FF272A64-4C11-4CC7-BD3D-D057C74BBEECQ38993256-F453AE7F-D979-4E5C-9C37-8C310D951C2BQ39138091-72AF5A6C-A2CA-4732-83EB-F3F6F3086C08Q40566915-C895EA5B-641C-41A0-B137-A44A372F7A80Q41095276-1E33F96F-6878-407F-B9DC-F64CC8F91C94Q41759508-37D3ACC8-4450-4C3F-82B3-89A7F5906328Q42361420-88F6A75C-CFFA-4C77-820F-DFFAFD879B5DQ42620905-25E80EBC-0C1B-483F-A9F2-C8319CD6A178Q45356332-3D3D96B1-43AC-4D31-B21D-258400CF4F04Q46235962-C5D4BC32-D583-4DF2-97F0-C374E1EAB73AQ46283475-4EE8B9FE-F518-4AA0-A491-13775A4C6BE1Q47293439-74D1D9C3-D3D5-4D16-AECB-05E4CDB05E11Q47423347-43D06D65-4D7B-44D1-902B-2FED1FEC4623Q47599462-E25AE326-DA2B-42B5-8C19-A24E41F7A982
P2860
Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemotherapy-induced periphera ...... sive update of the literature.
@en
Chemotherapy-induced periphera ...... sive update of the literature.
@nl
type
label
Chemotherapy-induced periphera ...... sive update of the literature.
@en
Chemotherapy-induced periphera ...... sive update of the literature.
@nl
prefLabel
Chemotherapy-induced periphera ...... sive update of the literature.
@en
Chemotherapy-induced periphera ...... sive update of the literature.
@nl
P2093
P2860
P356
P1476
Chemotherapy-induced periphera ...... nsive update of the literature
@en
P2093
Andreas A Argyriou
Athanasios P Kyritsis
Thomas Makatsoris
P2860
P304
P356
10.2147/CMAR.S44261
P407
P577
2014-03-19T00:00:00Z